About XTL Biopharmaceuticals Ltd. XTL is an IP Portfolio company that holds 100% of The Social Proxy Ltd. and IP portfolio including hCDR1 for Lupus (SLE) and Sjögren's Syndrome (SS) that the company ...
2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for ...
About XTL Biopharmaceuticals Ltd. XTL is an IP Portfolio company that holds 100% of The Social Proxy Ltd. and IP portfolio including hCDR1 for Lupus (SLE) and Sjögren's Syndrome (SS) that the company ...
But those results may (hopefully) be a thing of the past. Functional medicine doctors are bringing their integrative approach ...
Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying ...
Lantern Pharma Inc. , a pioneer in AI-driven precision oncology and computational therapeutic development, today announced the establishment of an A.I. Center of Excellence and Advanced Agentic Labs ...
A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...
Days later, Josh, then 23, from Chicago, Illinois, would regain consciousness in a hospital bed to learn surgeons had removed ...
Teddi Mellencamp has been open about her melanoma battle since first revealing her diagnosis in 2022. In February 2025, the ...
Investigators compared the risk of cancer onset in patients with lupus nephritis treatedwith calcineurin inhibitors vs ...
The musician opened up about his daughter, former reality star Teddi Mellencamp, on an episode of "The Joe Rogan Experience." ...
News-Medical.Net on MSN
Digital twin technology guides personalized treatment for brain cancer patients
A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback